Abstract
Background: Convolvulus pluricaulis is a native plant that is commonly mentioned in Ayurveda as a Rasayana and is primarily recommended for use in mental stimulation and rejuvenation therapy. Convolvulus pluricaulis is used as a brain tonic. The plant is reported to be a prominent memory-improving drug. It is used as a psychostimulant and tranquilizer. It is reported to reduce mental tension.
Objective: The present study aimed to explore the protective effect of hydroalcoholic extract from the leaves of Convolvulus pluricaulis along with CNS depressant and anti-anxiety activities, in models of mice.
Methods: The extract from leaves of Convolvulus pluricaulis were sequentially isolated with a mixture of water and alcohol solution in the soxhlet apparatus. An acute toxicity study was conducted as per OECD guidelines no. 423, in which 18 Albino male mice were treated with different doses (1, 10, 100, 500, 1000, and 2000 mg/kg) of hydroalcoholic extract of Convolvulus pluricaulis and assessed for toxicity parameters for 14 days. Various psychomotor activities of hydroalcoholic extract from leaves of Convolvulus pluricaulis for 100, 200, and 300 mg/kg doses were performed in mice by using various tests like actophotometer, open field, rota-rod, grip strength tests, elevated plus maze, hole board test, inclined plane, chimney test.
Results: The hydroalcoholic extract from leaves of Convolvulus pluricaulis was found to fall under category 4 in the acute toxicity study. Therefore, 100, 200, and 300 mg/kg doses of hydroalcoholic extract of leaves of Convolvulus pluricaulis were selected for the further pharmacological study. The results of psychomotor tests (actophotometer, open field, rota-rod, grip strength, hole board test, inclined plane, chimney test, elevated plus maze, light-dark model) for test doses 100, 200, and 300 in mice showed CNS depressant and anti-anxiety effects.
Conclusion: Hydroalcoholic extract from leaves of Convolvulus pluricaulis at the 100, 200, and 300 mg/kg doses has shown CNS depressant and anti-anxiety effects in mice models.
Graphical Abstract
[1]
Kessler, R.C.; Berglund, P.; Demler, O.; Jin, R.; Merikangas, K.R.; Walters, E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry, 2005, 62(6), 593-602.
[http://dx.doi.org/10.1001/archpsyc.62.6.593] [PMID: 15939837]
[http://dx.doi.org/10.1001/archpsyc.62.6.593] [PMID: 15939837]
[2]
Nicholas, A.; Nicki, R.; Brian, R. Davidson’s principles & practice of medicine; , 2006, pp. 238-240.
[3]
Liu, L.; Liu, C.; Wang, Y.; Wang, P.; Li, Y.; Li, B. Herbal medicine for anxiety, depression and insomnia. Curr. Neuropharmacol., 2015, 13(4), 481-493.
[http://dx.doi.org/10.2174/1570159X1304150831122734] [PMID: 26412068]
[http://dx.doi.org/10.2174/1570159X1304150831122734] [PMID: 26412068]
[4]
Flowers of India. India: Tabish; Flowers by botanical names-Convolvulus pluricaulis. [Online] http://www.flowersofindia.net/botanical.html. [Accessed on 14th November, 2013]
[5]
Kumar, D.C. Pharmacognosy can help minimize accidental misuse of herbal medicine. Curr. Sci., 2007, 93, 1356-1358.
[6]
Dubey, N.K.; Kumar, R.; Tripathi, P. Global promotion of herbal medicine: India’s opportunity. Curr. Sci., 2007, 86, 37-41.
[7]
Verma, S.; Singh, V.; Tanwar, S. Pharmacognostic validation of the whole plant of Convolvulus pluricaulis Choisy (Convolvulaceae). Int. J. Pharm. Pharm. Sci., 2012, 4, 241-246.
[8]
Kizhakke, P.A. Convolvulus pluricaulis (Shankhapushpi) ameliorates human microtubule-associated protein tau (hMAPT) induced neurotoxicity in Alzheimer’s disease Drosophila model. J. Chem. Neuroanat., 2019, Volume 95, January 2019, Pages, 115-122.
[http://dx.doi.org/10.1016/j.jchemneu.2017.10.002]
[http://dx.doi.org/10.1016/j.jchemneu.2017.10.002]
[10]
Ravichandra, V.D.; Ramesh, C.; Sridhar, K.A. Hepatoprotective potentials of aqueous extract of Convolvulus pluricaulis against thioacetamide induced liver damage in rats. Biomed. Aging Pathol., 2013, 3(3), 131-135.
[http://dx.doi.org/10.1016/j.biomag.2013.06.005]
[http://dx.doi.org/10.1016/j.biomag.2013.06.005]
[11]
Subramani, R; Anand, M; Muralidharan, P. Effect of Convolvulus pluricaulis Choisy in obsessive-compulsive disorder using animal models. 2012. A accessed on 6 january 2012.
[12]
Verma, S.; Sinha, R.; Singh, V.; Tanwar, S.; Godara, M. Antibacterial activity of methanolic extract of the whole plant of Convolvulus pluricaulis Choisy. J. Pharm. Res., 2011, 4(12), 4450.
[13]
Bihaqi, S.W.; Sharma, M.; Singh, A.P.; Tiwari, M. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J. Ethnopharmacol., 2009, 124(3), 409-415.
[http://dx.doi.org/10.1016/j.jep.2009.05.038] [PMID: 19505562]
[http://dx.doi.org/10.1016/j.jep.2009.05.038] [PMID: 19505562]
[14]
Nahata, A.; Patil, U.K.; Dixit, V.K. Anxiolytic activity of Evolvulus alsinoides and Convulvulus pluricaulis in rodents. Pharm. Biol., 2009, 47(5), 444-451.
[http://dx.doi.org/10.1080/13880200902822596]
[http://dx.doi.org/10.1080/13880200902822596]
[15]
Dhingra, D.; Valecha, R. Screening for the antidepressant-like activity of Convolvulus pluricaulis Choisy in mice. Pharmacologyonline, 2007, 1, 262-278.
[16]
Panda, S.; Kar, A. Inhibition of T3 production in levothyroxine-treated female mice by the root extract of Convolvulus pluricaulis. Horm. Metab. Res., 2001, 33(1), 16-18.
[http://dx.doi.org/10.1055/s-2001-12620] [PMID: 11280709]
[http://dx.doi.org/10.1055/s-2001-12620] [PMID: 11280709]
[17]
Bihaqi, S.; Tiwari, M.; Singh, A.P. In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats. Indian J. Pharmacol., 2011, 43(5), 520-525.
[http://dx.doi.org/10.4103/0253-7613.84958] [PMID: 22021993]
[http://dx.doi.org/10.4103/0253-7613.84958] [PMID: 22021993]
[18]
Sharma, K.; Arora, V.; Rana, A.C.; Bhatnagar, M. Anxiolytic effect of Convolvulus pluricaulis Choisy petals on the elevated plus-maze model of anxiety in mice. Herbal. Med. Toxicol., 2009, 3(1), 41-46.
[19]
Sharma, K.; Bhatnagar, M.; Kulkarni, S.K. Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: A comparative evaluation. Indian J. Exp. Biol., 2010, 48(5), 479-485.
[PMID: 20795365]
[PMID: 20795365]
[20]
Sairam, K.; Rao, C.V.; Goel, R.K. Effect of Convolvulus pluricaulis Chois on gastric ulceration and secretion in rats. Indian J. Exp. Biol., 2001, 39(4), 350-354.
[PMID: 11491580]
[PMID: 11491580]
[21]
Kothiyal, P.; Rawat, M.S. Comparative nootropic effect of Evolvulusalsinoides and Convolvulus pluricaulis Choisy. Int. J. Pharm. Biol. Sci., 2011, 2(1), 616-621.
[22]
Chaturvedi, G.N.; Sharma, R.K.; Sen, S.P. Hypotensive effect of certain indigenous drugs with special reference to Shankhapuspi in anaesthetized dogs. J. Res. Indian Med., 1996, 1(1), 57-67.
[23]
Roll, R.; Hofer-Bosse, Th.; Kayser, C. New perspectives in acute toxicity testing of chemicals. Toxicol. Lett. Suppl, 1986, 31, 86.
[24]
Barros, H.M.T.; Tannhauser, M.A.L.; Tannhauser, S.L.; Tannhauser, M. Enhanced detection of hyperactivity after drug withdrawal with a simple modification of the open-field apparatus. J. Pharmacol. Methods, 1991, 26(4), 269-275.
[http://dx.doi.org/10.1016/0160-5402(91)90037-6] [PMID: 1758193]
[http://dx.doi.org/10.1016/0160-5402(91)90037-6] [PMID: 1758193]
[25]
Kondziella, W. Eineneue Method ezur Messung der muskulaeren Relaxation beiweissen Maeussen. Arch. Int. Pharmacodyn., 1964, 152, 277-284.
[PMID: 14265648]
[PMID: 14265648]
[26]
Cartmell, S.M.; Gelgor, L.; Mitchell, D. A revised rotarod procedure for measuring the effect of antinociceptive drugs on motor function in the rat. J. Pharmacol. Methods, 1991, 26(2), 149-159.
[http://dx.doi.org/10.1016/0160-5402(91)90063-B] [PMID: 1943125]
[http://dx.doi.org/10.1016/0160-5402(91)90063-B] [PMID: 1943125]
[27]
Costall, B.; Jones, B.J.; Kelly, M.E.; Naylor, R.J.; Tomkins, D.M. Exploration of mice in a black and white test box: Validation as a model of anxiety. Pharmacol. Biochem. Behav., 1989, 32(3), 777-785.
[http://dx.doi.org/10.1016/0091-3057(89)90033-6] [PMID: 2740429]
[http://dx.doi.org/10.1016/0091-3057(89)90033-6] [PMID: 2740429]
[28]
Allmark, M.G.; Bachinski, W.M. A method of assay for curare using rats. J. Am. Pharm. Assoc. (Sci. Ed.), 1949, 38(1), 43-45.
[http://dx.doi.org/10.1002/jps.3030380114]
[http://dx.doi.org/10.1002/jps.3030380114]
[29]
Boissier, J.R.; Tardy, J.; Diverres, J.C. Une novella method simple pour exploreI’action‘’tranquillisante’’. Le test de la cheminee. Med. Exp., 1960, 3, 81-84.
[30]
Asif, M.; Dwivedi, J.; Yadav, S. Anti-depressant, anxiolytic and the muscle relaxant activity of hydroalcoholic extract of Cissampelos pareira Linn. Leaves. Cent. Nerv. Syst. Agents Med. Chem., 2021, 21(2), 114-124.
[http://dx.doi.org/10.2174/1871524921666210505101704] [PMID: 33964866]
[http://dx.doi.org/10.2174/1871524921666210505101704] [PMID: 33964866]
[31]
Boissier, J.R.; Simon, P. Dissociation de deuxcomposantesdans le comportementd’investigation de la souris. Arch Int Pharmacodyn, 1964, 147, 372-388.
[32]
Vogal, H. Drug discovery and evaluation; Springer: Berlin, 1997, p. 487.
[http://dx.doi.org/10.1007/978-3-662-03333-3]
[http://dx.doi.org/10.1007/978-3-662-03333-3]
[33]
Nutt, D.J.; Ballenger, J.C.; Sheehan, D.; Wittchen, H.U. Generalized anxiety disorder: Comorbidity, comparative biology and treatment. Int. J. Neuropsychopharmacol., 2002, 5(4), 315-325.
[http://dx.doi.org/10.1017/S1461145702003048] [PMID: 12466031]
[http://dx.doi.org/10.1017/S1461145702003048] [PMID: 12466031]
[34]
Tyrer, P.; Baldwin, D. Generalised anxiety disorder. Lancet, 2006, 368(9553), 2156-2166.
[http://dx.doi.org/10.1016/S0140-6736(06)69865-6] [PMID: 17174708]
[http://dx.doi.org/10.1016/S0140-6736(06)69865-6] [PMID: 17174708]
[35]
Nguyen, L.; Lucke-Wold, B.P.; Logsdon, A.F.; Scandinaro, A.L.; Huber, J.D.; Matsumoto, R.R. Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice. Neuroreport, 2016, 27(14), 1004-1011.
[http://dx.doi.org/10.1097/WNR.0000000000000646] [PMID: 27580401]
[http://dx.doi.org/10.1097/WNR.0000000000000646] [PMID: 27580401]
[36]
Nguyen, L.; Thomas, K.L.; Lucke-Wold, B.P.; Cavendish, J.Z.; Crowe, M.S.; Matsumoto, R.R. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacol. Ther., 2016, 159, 1-22.
[http://dx.doi.org/10.1016/j.pharmthera.2016.01.016] [PMID: 26826604]
[http://dx.doi.org/10.1016/j.pharmthera.2016.01.016] [PMID: 26826604]
[37]
Herrera-Ruiz, M.; García-Beltrán, Y.; Mora, S.; Díaz-Véliz, G.; viana, G.S.B.; Tortoriello, J.; Ramírez, G. Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J. Ethnopharmacol., 2006, 107(1), 53-58.
[http://dx.doi.org/10.1016/j.jep.2006.02.003] [PMID: 16530995]
[http://dx.doi.org/10.1016/j.jep.2006.02.003] [PMID: 16530995]
[38]
Hellión-Ibarrola, M.C.; Ibarrola, D.A.; Montalbetti, Y.; Kennedy, M.L.; Heinichen, O.; Campuzano, M.; Tortoriello, J.; Fernández, S.; Wasowski, C.; Marder, M.; De Lima, T.C.M.; Mora, S. The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. J. Ethnopharmacol., 2006, 105(3), 400-408.
[http://dx.doi.org/10.1016/j.jep.2005.11.013] [PMID: 16386395]
[http://dx.doi.org/10.1016/j.jep.2005.11.013] [PMID: 16386395]
[39]
Carro-Juárez, M.; Rodríguez-Landa, J.F.; Rodríguez-Peña, M.L.; Rovirosa-Hernández, M.J.; García-Orduña, F. The aqueous crude extract of Montanoa frutescens produces anxiolytic-like effects similarly to diazepam in Wistar rats: Involvement of GABAA receptor. J. Ethnopharmacol., 2012, 143(2), 592-598.
[http://dx.doi.org/10.1016/j.jep.2012.07.022] [PMID: 22885072]
[http://dx.doi.org/10.1016/j.jep.2012.07.022] [PMID: 22885072]
[40]
Brady, K.T.; Verduin, M.L. Pharmacotherapy of comorbidmood, anxiety, and substance use disorders. Subst Use Misuse., 2005, 40(13-14), 2021-41-2043-8.
[41]
Nierenberg, A.A. Current perspectives on the diagnosis and treatment of major depressive disorder. Am. J. Manag. Care, 2001, 7(11), S353-S366.
[PMID: 11570026]
[PMID: 11570026]
[42]
Patočka, J.; Jakl, J. Biomedically relevant chemical constituents of Valeriana officinalis. J. Appl. Biomed., 2010, 8(1), 11-18.
[http://dx.doi.org/10.2478/v10136-009-0002-z]
[http://dx.doi.org/10.2478/v10136-009-0002-z]
[43]
Benke, D.; Barberis, A.; Kopp, S.; Altmann, K.H.; Schubiger, M.; Vogt, K.E.; Rudolph, U.; Möhler, H. GABAA receptors as In vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology, 2009, 56(1), 174-181.
[http://dx.doi.org/10.1016/j.neuropharm.2008.06.013] [PMID: 18602406]
[http://dx.doi.org/10.1016/j.neuropharm.2008.06.013] [PMID: 18602406]
[44]
Neuhaus, W.; Trauner, G.; Gruber, D.; Oelzant, S.; Klepal, W.; Kopp, B.; Noe, C. Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier. Planta Med., 2008, 74(11), 1338-1344.
[http://dx.doi.org/10.1055/s-2008-1081343] [PMID: 18704879]
[http://dx.doi.org/10.1055/s-2008-1081343] [PMID: 18704879]
[45]
Awad, R.; Levac, D.; Cybulska, P.; Merali, Z.; Trudeau, V.L.; Arnason, J.T. Effects of traditionally used anxiolytic botanicals on enzymes of the γ-aminobutyric acid (GABA) systemThis article is one of a selection of papers published in this special issue (part 1 of 2) on the safety and efficacy of natural health products. Can. J. Physiol. Pharmacol., 2007, 85(9), 933-942.
[http://dx.doi.org/10.1139/Y07-083] [PMID: 18066140]
[http://dx.doi.org/10.1139/Y07-083] [PMID: 18066140]
[46]
Pearl, P.L.; Gibson, K.M. Clinical aspects of the disorders of GABA metabolism in children. Curr. Opin. Neurol., 2004, 17(2), 107-113.
[http://dx.doi.org/10.1097/00019052-200404000-00005] [PMID: 15021235]
[http://dx.doi.org/10.1097/00019052-200404000-00005] [PMID: 15021235]
[47]
Kumar, V. Potential medicinal plants for CNS disorders: An overview Phytother Res., 2006, 20(12), 1023-1035.
[48]
Spinella, M. The psychopharmacology of herbal medicine: Plant drugs that alter mind, brain and behavior (paperback); MIT Press: Cambridge, 2001.
[49]
Shah, V.; Bole, P.V. Botanical identity of Shankapushpi. Indian J. Pharm., 1961, 23(8), 223-22.
[50]
Bahramsoltani, R.; Farzaei, M.H.; Farahani, M.S.; Rahimi, R. Phytochemical constituents as future antidepressants: A comprehensive review. Rev. Neurosci., 2015, 26(6), 699-719.
[http://dx.doi.org/10.1515/revneuro-2015-0009] [PMID: 26146123]
[http://dx.doi.org/10.1515/revneuro-2015-0009] [PMID: 26146123]
Related Books
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research-Dementia
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
